13F Holdings
中文EN

RTGN RetinalGenix Technologies Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1836295 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY24.0%
TTM EPS YoY26.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-10,293.8%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets8,297.1%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.23x
Accruals ratio-7,939.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$83,040$373,271$524,183$809,255$747,808
SG&A expense$1.30M$1.33M$898,658$807,406$1.12M
Interest expense$4,005$3,840$3,840$5,140$2,619
Net income-$2.43M-$4.32M-$2.09M-$3.91M-$2.18M
EPS (basic)-0.13-0.24-0.12-0.25-0.05
EPS (diluted)-0.13-0.24-0.12-0.25-0.05
Weighted avg. shares (diluted)18.56M17.94M17.35M15.58M41.25M
Balance sheet
Cash & equivalents$14,774$6,060$0$38$4,947
Current assets$14,774$6,060$0$38$4,947
PP&E, net—$56$156$256—
Total assets$21,041$14,946$156$294$4,947
Current liabilities$2.32M$1.47M$1.41M——
Total liabilities$2.32M$1.48M$1.41M$1.07M$469,622
Shareholders' equity-$2.30M-$1.46M-$1.41M-$1.07M-$464,675
Shares outstanding18.84M18.52M17.64M17.27M14.22M
Cash flow statement
Operating cash flow-$558,350-$741,936-$451,661-$199,287-$1.17M
Financing cash flow$567,064$747,996$451,623$194,685$1.17M
Depreciation & amortization$56$100$100$51—
Stock-based compensation$1.04M$2.61M$664,208$259,300$307,918

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.